Cirsium Biosciences website screenshot

Cirsium Biosciences

Cirsium Biosciences is a biotechnology company democratizing gene therapy through transformative manufacturing methods. It develops viral vector production systems that use whole plants as bioreactors, offering a highly scalable, linear scale-out platform for producing recombinant AAV (adeno-associated virus) vectors. The plant-based, controlled-environment agriculture approach targets the industry's core production bottlenecks - inadequate global capacity, poor scalability, high clinical-grade manufacturing costs, and standardization challenges - claiming up to a 70% reduction in manufacturing lead times. Cirsium is a private, venture-backed therapeutics-manufacturing firm and is tracked in the API Evangelist network as a company profile; it does not currently publish a public developer API.

Cirsium Biosciences is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Gene Therapy, Biotechnology, and Manufacturing.

Cirsium Biosciences’ developer surface includes engineering blog, support, and 5 more developer resources.

15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotech TherapeuticsGene TherapyBiotechnologyManufacturingAAV VectorsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 15.0/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/cirsium-biosciences: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Cirsium Biosciences Domain Security

TLSv1.3 · HSTS · DNSSEC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: cirsium-biosciences
name: Cirsium Biosciences
description: Cirsium Biosciences is a biotechnology company democratizing gene therapy through transformative manufacturing
  methods. It develops viral vector production systems that use whole plants as bioreactors, offering a highly scalable, linear
  scale-out platform for producing recombinant AAV (adeno-associated virus) vectors. The plant-based, controlled-environment
  agriculture approach targets the industry's core production bottlenecks - inadequate global capacity, poor scalability,
  high clinical-grade manufacturing costs, and standardization challenges - claiming up to a 70% reduction in manufacturing
  lead times. Cirsium is a private, venture-backed therapeutics-manufacturing firm and is tracked in the API Evangelist network
  as a company profile; it does not currently publish a public developer API.
url: https://raw.githubusercontent.com/api-evangelist/cirsium-biosciences/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cirsiumbio.com/wp-content/uploads/2023/05/Cirsium-Biosciences-Color-Logo.svg
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
- phifund-ventures
- kdt-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech Therapeutics
- Gene Therapy
- Biotechnology
- Manufacturing
- AAV Vectors
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://cirsiumbio.com/
- type: PrivacyPolicy
  url: https://cirsiumbio.com/privacy-policy/
- type: TermsOfService
  url: https://cirsiumbio.com/terms-and-conditions/
- type: Blog
  url: https://cirsiumbio.com/news/
- type: Support
  url: https://cirsiumbio.com/contact/
- type: LinkedIn
  url: https://www.linkedin.com/company/74907887/
- type: DomainSecurity
  url: security/cirsium-biosciences-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence